Literature DB >> 32733010

Letter to the Editor: Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality.

A Sutra Del Galy1,2, A Marouf1, E Raffoux3, M Robin1, D Michonneau1,2,4, M Sébert5, F Sicre de Fontebrune1, A Xhaard1, E Lengline3, R Itzykson2,3, C Frieri1,2, H Dombret2,3, P Fenaux2,5, R Peffault de Latour1,2, L Adès2,5, G Socié6,7,8.   

Abstract

Entities:  

Year:  2020        PMID： 32733010     DOI： 10.1038/s41375-020-1004-9

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  4 in total

1.  Life expectancy and burden of late complications after reduced intensity conditioning allogeneic transplantation.

Authors:  Adrien Rousseau; Antoine Capes; Aurélien Sutra Del Galy; David Michonneau; Marie Robin; Flore Sicre de Fontbrune; Aliénor Xhaard; Camilla Frieri; Lionel Adès; Emmanuel Raffoux; Chantal Himberlin; Mathilde Baudet; Régis Peffault de Latour; Gérard Socié
Journal:  Bone Marrow Transplant       Date:  2022-06-02       Impact factor: 5.174

Review 2.  How old is too old for a transplant?

Authors:  Daniel Weisdorf
Journal:  Best Pract Res Clin Haematol       Date:  2021-01-12       Impact factor: 3.020

Review 3.  Current status of clinical trials assessing mesenchymal stem cell therapy for graft versus host disease: a systematic review.

Authors:  Ying Li; Jie Hao; Zheng Hu; Yong-Guang Yang; Qi Zhou; Liguang Sun; Jun Wu
Journal:  Stem Cell Res Ther       Date:  2022-03-04       Impact factor: 6.832

4.  Not all patients with AML over 60 years of age should be offered early allogeneic stem cell transplantation.

Authors:  H Joachim Deeg
Journal:  Blood Adv       Date:  2022-03-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.